FAP mutations destabilize transthyretin facilitating conformational changes required for amyloid formation

CIBA Foundation Symposia

Volumn , Issue 199, 1996, Pages 228-242

  Colon, Wilfredo ^a   Lai, Zhihong ^a   McCutchen, Sandra L ^a   Miroy, Greta J ^a   Strang, Candace ^a   Kelly, Jeffery W ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

AMYLOIDOSIS; ARTICLE; BIOSYNTHESIS; CHEMICAL STRUCTURE; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMYLOID; AMYLOIDOSIS; HUMANS; MODELS, MOLECULAR; MUTATION; PREALBUMIN; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 0030337529     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Sc: an α-helix to β-sheet transition. Philos Trans R Soc Lond Ser B Biol Sci 343:435-441
2. Benson MD 1989 Familial amyloidotic polyneuropathy. Trends Biol Sci 12:88-92
3. Benson MD, Wallace MR 1989 Amyloidosis, the metabolic basis of disease. In: Scriver CP, Beaudet AL, Sly WS, Valles D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, p 2439-2460
4. Blake CCF, Geisow MJ, Rerat B, Rerat C, Swan IDA 1974 Structure of human plasma prealbumin at 2.5 Å resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol 88:1-12
5. Blake CCF, Geisow MJ, Oatley SJ, Rerat B, Rerat C 1978 Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 121:339-356
6. Castaño EM, Frangione B 1988 Biology of disease: human amyloidosis, Alzheimer disease and related disorders. Lab Invest 58:122-132
7. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS 1991 Secondary structural analysis of the scrapie-associated protein Prp 27-30 in water by infrared spectroscopy. Biochemistry 30:7672-7680
8. Colon W, Kelly JW 1991 Transthyretin acid induced denaturation is required for amyloid fibril formation in vitro. Applications of enzyme biotechnology. Plenum, New York, p 99-108
9. Colon W, Kelly JW 1992 Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31:8654-8660
10. Come JH, Lansbury PT Jr 1994 Predisposition of prion protein homozygotes to Creutzfeldt-Jakob Disease can be explained by a nucleation-dependent polymerization mechanism. J Am Chem Soc 116:4109-4110
11. Cornwell GC, Sletten K, Johansson B, Westermark P 1988 Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 154:648-653
12. Daggett V 1995 Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implication for scrapie formation. Chem Biol 2:305-315
13. Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W, Page DL 1971 Creation of amyloid fibrils from Bence-Jones proteins in vitro. Science 174:712-714
14. Gustavsson A, Engström U, Westermark P 1991 Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun 175:1159-1164
15. Hamilton JA, Steinrauf LK, Liepnieks J et al 1992 Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochim Biophys Acta 1139:9-16
16. Hurle MR, Helms LR, Li L, Chan W, Wetzel R 1994 A role for destabilizing amino acid replacements in light chain amyloidosis. Proc Natl Acad Sci 91:5446-5450
17. Jacobson DR, Buxbaum JN 1991 Genetic aspects of amyloidosis. Adv Hum Genet 20:69-123
18. Kelly JW 1996 Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6:11-17
19. Kelly JW, Lansbury PT Jr 1994 A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation. Amyloid: Int J Exp Clin Invest 1:186-205
20. Kisilevsky R 1983 Biology of disease amyloidosis: a familiar problem in light of current pathogenic developments. Lab Invest 49:381-390
21. Lai Z, Colon W, Kelly JW 1996 The acid-mediated denaturation pathway of transthyretin yields an intermediate which can self-assemble into amyloid. Biochemistry, in press
22. Lansbury PT 1992 In pursuit of the molecular structure of the amyloid plaque: new technology provides unexpected and critical information. Biochemistry 31:6865-6870
23. Lansbury PT 1995 The chemistry of the scrapie infection: implications of the ICE 9 metaphor. Chem Biol 2:1-5
24. Lee JP, Stimson ER, Ghilardi JR et al 1995 H-1 NMR of Aβ amyloid peptide congeners in water solution-conformational changes correlate with plaque competence. Biochemistry 34:5191-5200
25. McCutchen S, Colon W, Kelly JW 1993 Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32:12119-12127
26. McCutchen SL, Lai Z, Miroy G, Kelly JW, Colon W 1995 Comparison of lethal and non-lethal transthyretin variants and their relationship to amyloid disease. Biochemistry 34:13527-13536
27. Miroy GJ, Kelly JW 1996 Working model of the structure of the transthyretin amyloidogenic intermediate based on proteolysis sensitivity and biophysical studies. Biochemistry, submitted
28. Monaco HL, Rizzi M, Coda A 1995 Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268:1039-1041
29. Nguyen J, Baldwin MA, Cohen FE, Prusiner SB 1995 Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochemistry 34:4186-4192
30. Pan KM, Baldwin M, Nguyen J et al 1993 Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90:10962-10966
31. Pepys MB 1994 Amyloidosis. In: Frank MM, Austen KF, Claman HN, Unanue ER (eds) Samter's immunologic diseases, 5th edn. Little, Brown & Co., Boston, MA, p 637-655
32. Pepys MB, Hawkins PN, Booth DR et al 1993 Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362:553-557
33. Raz A, Goodman DS 1969 The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complexes. J Biol Chem 244:3230-3237
34. Safar J, Roller PP, Gajdusek DC, Gibbs CJ 1993 Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci 2:2206-2216
35. Safar J, Roller PP, Gajdusek DC, Gibbs CJ 1994 Scrapie amyloid prion protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33:8375-8383
36. Sakaki Y, Yoshioka K, Tanahashi H, Furuya H, Sasaki H 1989 Human transthyretin (prealbumin) gene and molecular genetics of familial amyloid polyneuropathy. Mol Biol Med 6:161-168
37. Saraiva MJM 1995 Transthyretin mutations in health and disease. Hum Mutat 5:191-196
38. Saraiva MJM, Birken S, Costa PP, Goodman DS 1984 Amyloid fibril protein in familial polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 74:104-119
39. Seubert P, Vigo-Pelfry C, Esch F et al 1992 Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327
40. Shoji M, Golde TE, Ghiso J et al 1992 Production of the Alzheimer's amyloid β-protein by normal proteolytic processing. Science 258:126-129
41. Sipe JD 1994 Amyloidosis. Clin Lab Sci 31:325-354
42. Terry CJ, Damas AM, Oliviera P et al 1993 Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 12:735-741
43. Westermark P, Sletten K, Johansson B, Cornwell GGI 1990 Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843-2845
44. Zhang H, Kaneko K, Nguyen JT et al 1995 Conformational transitions on peptides containing two putative α-helices of the prion protein. J Mol Biol 250:514-526